Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and β-amyloid pathologies

Neuroscience

Volumn 92, Issue 2, 1999, Pages 499-513

  Kelliher, M ^a   Fastbom, J ^b   Cowburn, R F ^b   Bonkale, W ^b   Ohm, T G ^c   Ravid, R ^d   Sorrentino, V ^e   O'Neill, C ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^e SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

amyloid; Alzheimer's disease; Calcium homeostasis; Human brain; Neurofibrillary tangles; Ryanodine receptors

Indexed keywords

AMYLOID BETA PROTEIN; CALCIUM; CALCIUM CHANNEL; RYANODINE RECEPTOR;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTORADIOGRAPHY; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; DISEASE PROGRESSION; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; PUTAMEN; RYANODINE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 0033059445     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00042-1     Document Type: Article

References (84)

1. Alcazar A., Martin de la Vega C., Bazan E., Fando J.L., Salinas M. Calcium mobilization by ryanodine promotes the phosphorylation of initiation factor 2α subunit and inhibits protein synthesis in cultured neurons. J. Neurochem. 69:1997;1703-1708.
2. Arendt T., Holzer M., Großmann A., Zedlick D., Bruckner M.K. Increased expression and subcellular translocation of the mitogen-activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease. Neuroscience. 68:1995;5-18.
3. Berridge M.J. Elementary and global aspects of calcium signalling. J. exp. Biol. 200:1997;315-319.
4. Braak H., Braak E. Neuropathological staging of Alzheimer's related changes. Acta neuropath., Berlin. 82:1991;239-259.
5. Braak H., Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta neurol. scand. 165(Suppl.):1996;3-12.
6. Brandt N.R., Caswell A.H., Brandt T., Brew K., Mellgren R.L. Mapping of the calpain proteolysis products of the junctional foot protein of the skeletal muscle triad junction. J. Membr. Biol. 127:1992;35-47.
7. Breuer A.C., Bond M., Atkinson M.B. Fast axonal transport is modulated by altering trans-axolemmal calcium flux. Cell Calcium. 13:1992;249-262.
8. Brillantes A.-M. B., Ondrias K., Scott A., Kobrinsky E., Ondriasova E., Moschella M.C., Jayaraman T., Landers M., Ehrlich B.E., Marks A.R. Stabilisation of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell. 77:1994;513-523.
9. Brooks S.P.J., Storey K.B. Bound and determined: a computer program for making buffers of defined ion concentrations. Analyt. Biochem. 201:1992;119-126.
10. Brun A. An overview of light and microscopic changes. (1983) In Alzheimer's Disease: The Standard Reference. (ed. Reisberg B.), pp. 37-47, Free Press, New York.
11. 2+ flux. Cell. 83:1995;463-472.
12. Cavallaro S., Meiri N., Yi C.-L., Musco S., Ma W., Goldberg J., Alkon D.L. Late memory-related genes in the hippocampus revealed by RNA fingerprinting. Proc. natn. Acad. Sci. U.S.A. 94:1997;9669-9673.
13. Chavis P., Fagni L., Lansman J.B., Bockaert J. Functional coupling between ryanodine receptors and L-type calcium channels in neurons. Nature. 382:1996;719-722.
14. Chu A., Diaz-Munoz M., Hawkes M.J., Brush K., Hamilton S.L. Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel. Molec. Pharmac. 37:1990;735-741.
15. Cook D.G., Sung J.C., Golde T.E., Felsenstein K.M., Wojczyk B.S., Tanzi R.E., Trojanowski J.Q., Lee V. M.-Y., Doms R.W. Expression and analysis of presenilin 1 in a human neuronal system: localisation in cell bodies and dendrites. Proc. natn. Acad. Sci. U.S.A. 93:1996;9223-9228.
16. Cook D.G., Forman M.S., Sung J.C., Leight S., Kolson D.L., Iwatsubo T., Lee V. M.-Y., Doms R.W. Alzheimer's Aβ(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nature Med. 3:1997;1021-1023.
17. Coronado R., Morrissette J., Sukhareva M., Vaughan D.M. Structure and function of ryanodine receptors. Am. J. Physiol. 266:1994;C1485-C1504.
18. Cowburn R.F., O'Neill C., Ravid R., Alafuzoff I., Winblad B., Fowler C.J. Adenylyl cyclase activity in postmortem human brain: evidence for altered G protein mediation in Alzheimer's disease. J. Neurochem. 58:1992;1409-1419.
19. Cowburn R.F., Fowler C.J., O'Neill C. Neurotransmitter receptor/G protein mediated signal transduction in Alzheimer's disease brain. Neurodegeneration. 5:1996;483-488.
20. Fiorillo C.D., Williams J.T. Glutamate mediates an inhibitory post-synaptic potential in dopamine neurons. Nature. 394:1998;78-82.
21. Flynn D.D., Ferrari-DiLeo G., Mash D.C., Levey A.I. Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease. J. Neurochem. 64:1995;1888-1891.
22. 2+ release channels are differentially expressed in rabbit brain. J. Neurosci. 14:1994;4794-4805.
23. 4 binding in Alzheimer's disease brain. Brain Res. 681:1995;160-166.
24. Geary W.A., Toga A.W., Wooten G.F. Quantitative film autoradiography for tritium methodological considerations. Brain Res. 337:1985;99-108.
25. Ghosh A., Greenberg M.E. Calcium signalling in neurons: molecular mechanisms and cellular consequences. Science. 268:1995;239-247.
26. Giannini G., Conti A., Mammarella S., Scrobogna M., Sorrentino V. The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues. J. Cell Biol. 128:1995;893-904.
27. Gong C.-X., Singh T.J., Grundke-Iqbal I., Iqbal K. Alzheimer's disease abnormally phosphorylated τ is dephosphorylated by protein phosphatase-2B (calcineurin). J. Neurochem. 62:1994;803-806.
28. Gong C.-X., Shaikh S., Wang J.-Z., Zaidi T., Grundke-Iqbal I., Iqbal K. Phosphatase activity towards abnormally phosphorylayed τ: decrease in Alzheimer disease brain. J. Neurochem. 65:1995;732-738.
29. Greenwood A.F., Powers R.E., Jope R.S. Phosphoinositide hydrolysis, G alpha q, phospholipase C, and protein kinase C in post mortem human brain: effects of post mortem interval, subject age, and Alzheimer's disease. Neuroscience. 69:1995;125-138.
30. Grynspan F., Griffin W.R., Cataldo A., Katayama S., Nixon R.A. Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease. Brain Res. 763:1997;145-158.
31. Guo Q., Furukawa K., Sopher B.L., Pham D.G., Xie J., Robinson N., Martin G.M., Mattson M.P. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitises PC-12 cells to death induced by amyloid β-peptide. NeuroReport. 8:1996;379-383.
32. Guo Q., Sopher B.L., Furukawa K., Pham D.G., Robinson N., Martin G.M., Mattson M.P. Alzheimer's presenilin mutation sensitises neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17:1997;4212-4222.
33. Hain J., Onoue H., Mayrleitner M., Fleischer S., Schindler H. Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from cardiac muscle. J. biol. Chem. 270:1995;2047-2081.
34. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;154-159.
35. Hartmann T., Bieger S.C., Bruhl B., Tienari P.J., Ida N., Allsop D., Roberts G.W., Masters C.L., Dotti C.G., Unsicker K., Beyreuther K. Distinct sites of intracellular production for Alzheimer's Aβ40/42 amyloid peptides. Nature Med. 3:1998;1016-1020.
36. Hutton M., Hardy J. The presenilins and Alzheimer's disease. Human molec. Genet. 6:1998;1639-1646.
37. Johnson G.V.W., Jenkins S.M. Tau protein in normal and Alzheimer's disease brain. Alzheimer's Dis. Rev. 1:1996;38-54.
38. Jolly-Tornetta C., Gao Z.-Y., Lee V. M.-Y., Wolf B.A. Regulation of amyloid precursor protein secretion by glutamate receptors in human Ntera 2 neurons (NT2N). J. biol. Chem. 273:1998;14015-14021.
39. Jope R.S., Song L., Powers R.E. Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain. Neurobiol. Aging. 18:1997;111-120.
40. Kawai T., Watanabe M. Effects of ryanodine on spike after-hyperpolarisation in sympathetic neurones of the rat superior cervical ganglion. Pflügers Arch. Eur. J. Physiol. 413:1989;470-475.
41. Khatchaturian Z.S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105.
42. Kovacs D.M., Fausett H.J., Page K.J., Kim T.-W., Moir R.D., Merriam D.E., Hollister R.D., Hallmark O.G., Mancini R., Felsenstein K.M., Hyman B.T., Tanzi R.E., Wasco W. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Med. 2:1996;224-229.
43. Kurumatani T., Fastbom J., Bonkale W.L., Bogdanovic N., Winblad B., Ohm T.G., Cowburn R.F. Loss of inositol 1,4,5-trisphosphate receptor sites and decreased PKC levels correlate with staging of Alzheimer's disease neurofibrillary pathology. Brain Res. 796:1998;209-221.
44. Ladner C.J., Celesia G.G., Magnusson D.J., Lee J.M. Regional alterations in M1 muscarinic receptor-G protein coupling in Alzheimer's disease. J. Neuropath. exp. Neurol. 54:1995;783-789.
45. Laemmli U.K. Cleavage of structural proteins during assembly of the macrophage T4. Nature. 227:1970;680-685.
46. Lah J.J., Heilman C.J., Nash N.R., Rees H.D., Yi H., Counts S.E., Levey A.I. Light and electron microscopic localization of presenilin-1 in primate brain. J. Neurosci. 17:1997;1971-1980.
47. Lokuta A.J., Meyers M.B., Sander P.R., Fishman G.I., Valdivia H.H. Modulation of cardiac ryanodine receptors by sorcin. J. biol. Chem. 272:1997;25333-25388.
48. Makrill J.J., Challiss R.A.J., O'Connell D.A., Lai F.A., Nahorski S.R. Differential expression and regulation of ryanodine receptor and myo-inositol 1,4,5-trisphosphate receptor calcium release channels in mammalian tissues and cell lines. Biochem. J. 327:1997;251-258.
49. Markwell M.A.K., Haas S.M., Bieber L.L., Tolbert N.E.A. Modification of the standard Lowry procedure to simplify protein determination in membranes and lipoprotein samples. Analyt. Biochem. 87:1978;206-210.
50. Mattson M.P., Engle M.G., Rychlik B. Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cerebral cortical neurones. Molec. chem. Neuropath. 15:1991;117-142.
51. Mattson M.P., Guo Q., Furukawa K., Pedersen W.A. Presenilins, the endoplasmic reticulum and neuronal apoptosis in Alzheimer's disease. J. Neurochem. 70:1998;1-14.
52. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: a report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
53. 2+ release channel. J. biol. Chem. 268:1993;19785-19790.
54. 2+ release channels and their regulation by endogenous effectors. A. Rev. Physiol. 56:1994;485-508.
55. 2+ channels. J. biol. Chem. 273:1998;18930-18935.
56. Michalak M., Dupraz P., Shoshan-Barmatz V. Ryanodine binding to sarcoplasmic reticulum membrane; comparison between cardiac and skeletal muscle. Biochim. biophys. Acta. 939:1988;587-594.
57. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment for Alzheimer's disease. Neurology. 41:1991;479-486.
58. Munson P.J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Analyt. Biochem. 107:1980;220-239.
59. Nishimura M., Tsubak K., Yagasaki O., Ito K. Ryanodine facilitates calcium dependent release of transmitter at mouse neuromuscular junction. Br. J. Pharmac. 100:1990;114-118.
60. Nixon R.A., Saito K.I., Grynspan F., Griffin W.R., Katayama S., Honda T., Mohan P.S., Shea T.B., Beerman M. Calcium activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann. N.Y. Acad. Sci. 747:1994;77-91.
61. Ohm T.G., Braak E., Bohl J., Braak H. A competition between silver-stain and immunocytochemistry. J. neural. Transm. 1:1989;111.
62. Ohm T.G., Muller H., Braak H., Bohl J. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience. 64:1995;209-217.
63. Ohm T.G., Scmitt M., Bohl J., Lemmer B. Decrease in adenylate cyclase activity antecedes neurofibrillary tangle formation. Neurobiol. Aging. 18:1997;275-279.
64. O'Neill C., Fowler C.J., Wiehager B., Cowburn R.F., Alafuzoff I., Winblad B. Coupling of human brain cerebral cortical α2-adrenoreceptors to GTP-binding proteins in Alzheimer's disease. Brain Res. 563:1991;39-43.
65. O'Neill C., Fowler C.J., Wiehager B., Ravid R., Winblad B., Cowburn R.F. Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain. Brain Res. 636:1994;193-201.
66. Padua R.A., Nagy J.I., Geiger J.D. Ionic strength of calcium, adenine nucleotide, magnesium and caffeine actions on ryanodine receptors in rat brain. J. Neurochem. 62:1994;2340-2348.
67. Paschen W., Doutheil J., Gissel C., Treiman M. Depletion of neuronal endoplasmic reticulum calcium stores by thapsigargin: effect on protein synthesis. J. Neurochem. 67:1996;1735-1743.
68. Pearson R.C.A., Powell T.P.S. The neuroanatomy of Alzheimer's disease. Rev. Neurosci. 2:1989;101-122.
69. Querfurth H.W., Jiang J.M., Geiger J.D., Selkoe D.J. Caffeine stimulates amyloid β-peptide release from β-amyloid precursor protein-transfected HEK293 cells. J. Neurochem. 69:1997;1580-1591.
70. 2+ release channel. Circulation Res. 67:1990;84-96.
71. Reisberg B., Ferris S.H., deLeon M.J., Crook T. The global deterioration scale (GDS): an instrument for the assessment of the primary degenerative dementia. Am. J. Psychiat. 139:1982;1136-1139.
72. Saito K.-I., Elce J.S., Hamos J.E., Nixon R.A. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. natn. Acad. Sci. U.S.A. 90:1993;2628-2632.
73. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kakull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. The amyloid β protein deposited in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2:1996;864-870.
74. 2+ release channels in rat brain. J. Neurosci. 13:1993;3051-3063.
75. Shimohama S., Sasaki Y., Fujimoto S., Kamiya S., Taniguchi T., Takenawa T., Kimura J. Phospholipase C isoenzymes in the human brain and their changes in Alzheimer's disease. Neuroscience. 82:1998;999-1007.
76. 2+ release channel in skeletal muscle. J. Membr. Biol. 142:1994;281-288.
77. Simpson P.B., Challiss R.A.J., Nahorski S.R. Neuronal calcium stores: activation and function. Trends Neurosci. 18:1995;299-305.
78. 2+ mobilization from stores expressing inositol 1,4,5-trisphosphate receptors and ryanodine receptors in cerebellar granule neurones. J. Neurochem. 67:1996;364-373.
79. Smith S.M., Nahorski S.R. Characterisation and distribution of inositol polyphosphate and ryanodine receptors in the rat brain. J. Neurochem. 60:1993;1605-1614.
80. 3H]ryanodine binding sites in postmortem human brain: regional distribution and effects of calcium, magnesium and caffeine. Brain Res. 58:1992;5349-5354.
81. Timerman A.P., Wiederrecht G., Marcy A., Fleischer S. Characterisation of an exchange reaction between soluble FKBP-12 and the FKBP ryanodine receptor complex. J. biol. Chem. 270:1996;2451-2459.
82. Verkhratsky A., Schmigol A. Calcium-induced calcium release in neurones. Cell Calcium. 19:1996;1-14.
83. Walter J., Capell A., Grunberg J., Pesold B., Schindzielorz A., Prior R., Podlinsky M.B., Fraser P., St. George-Hyslop P.H., Selkoe D.J., Haass C. The Alzheimer's disease associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Molec. Med. 2:1996;673-691.
84. Younkin S.G. Evidence that A beta 42 is the real culprit in Alzheimer's disease. Ann. Neurol. 37:1995;287-288.